Sabrina Shebes
Adult Health · Smithtown, NYNPI 1629693536
Payments from drug & device makers
Across 487 payments — averaging $21.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Medtronic$858
- Boston Scientific$756
- Collegium Pharmaceutical, Inc.$639
- Relievant Medsystems, Inc.$615
- Abbott$606
- plus $5K from 32 others
What the payments were for
- Travel & lodging$3904%
- Food & beverage$10,17296%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 106 | $1,814 |
| Medtronic | 28 | $858 |
| Boston Scientific | 14 | $756 |
| Collegium Pharmaceutical, Inc. | 77 | $639 |
| Relievant Medsystems, Inc. | 7 | $615 |
| Abbott | 9 | $606 |
| Biotronik NRO, Inc. | 6 | $521 |
| MML US, Inc. | 6 | $414 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 39 | $392 |
| Amgen(2 entities) | 16 | $340 |
| Arbor Pharmaceuticals, Inc. | 44 | $336 |
| Scilex Pharmaceuticals Inc. | 16 | $312 |
| IBSA Pharma Inc. | 6 | $309 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $216 |
| Valinor Pharma, LLC | 18 | $214 |
| Virtus Pharmaceuticals LLC | 10 | $189 |
| Biodelivery Sciences International, Inc. | 21 | $184 |
| Biohaven Pharmaceuticals, Inc. | 5 | $166 |
| Vertos Medical, Inc. | 1 | $163 |
| Redhill Biopharma Inc. | 7 | $157 |
| Pfizer | 7 | $155 |
| Atricure, Inc. | 1 | $142 |
| Painteq LLC | 1 | $139 |
| Abiomed | 1 | $106 |
| Nalu Medical, Inc. | 1 | $103 |
| Supernus Pharmaceuticals, Inc. | 5 | $98 |
| Vertex | 3 | $93 |
| Almatica Pharma LLC | 5 | $90 |
| Lundbeck LLC | 5 | $77 |
| Protega Pharmaceutials Inc | 4 | $61 |
| Forte Bio-pharma LLC | 3 | $58 |
| Curonix LLC | 1 | $49 |
| Averitas Pharma Inc. | 2 | $43 |
| Nevro Corp. | 2 | $38 |
| Si-bone, Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $33 |
| Convatec Inc. | 1 | $23 |
| Bioventus LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$1,222
- Prospera$452
- PROCLAIM$389
- ReActiv8$258
- UBRELVY$228
- Superion Indirect Decompression System$173
- mild Device Kit$163
- GENERAL PAIN MANAGEMENT$142
- ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM$142
- SYNERGY ABLATION SYSTEM$142
- ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2)$142
- PAINTEQ$139
- Tirosint$133
- Licart$133
- FLECTOR$133
- INCEPTIV$126
- NURTEC ODT$125
- QULIPTA$125
- Impella$106
- Nalu Neurostimulation System$103
How this compares
$10,563 in reported general payments places this provider in the 95th percentile of 3,828 adult health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 28 | $22,576 |
| MovantikNaloxegol Oxalate | 48 | $21,222 |
| BelbucaBuprenorphine Hcl | 25 | $18,233 |
| Oxymorphone Hcl ErOxymorphone Hcl | 11 | $16,897 |
| OxycontinOxycodone Hcl | 29 | $11,799 |
| ZtlidoLidocaine | 14 | $11,370 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 201 | $5,362 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 221 | $4,905 |
| Buprenorphine | 22 | $4,392 |
| Lidocaine | 30 | $3,255 |
| Diclofenac Sodium | 32 | $3,230 |
| Oxycodone Hcl | 183 | $3,169 |
| Morphine Sulfate ErMorphine Sulfate | 104 | $2,641 |
| Gabapentin | 224 | $2,147 |
| Pregabalin | 69 | $1,885 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $639 | $40,80953 claims |
| Redhill Biopharma Inc.Movantik | $157 | $21,22248 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $312 | $11,37014 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,828 adult health providers in New York.
Other adult health in Smithtown
- Marguerite CallahanNew York$1.4M
- Donna CatameroNew York$279K
- Kristen DurkinPort Jefferson Station$255K
- Katelyn McCormackAmherst$201K
- Mary CiechoskiBuffalo$200K
- Patricia LorussoLancaster$161K
- Jennifer FioriniGlens Falls$151K
- Tia AlbroRochester$142K
- Maria Gigante-BaggettEast Syracuse$92K
- Jane PattersonRochester$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.